6/18/2021  5:35:11 PM Chg. -0.375 Volume Bid6/18/2021 Ask5:35:39 PM Market Capitalization Dividend Y. P/E Ratio
45.195EUR -0.82% 2.58 mill.
Turnover: 116.32 mill.
-Bid Size: - -Ask Size: - 25.2 bill.EUR 1.95% 14.77

Business description

Fresenius is a health care group with international operations, providing products and services for dialysis, hospital and outpatient medical care.
 

Management board & Supervisory board

CEO
Stephan Sturm
Management board
Rachel Empey, Dr. Ernst Wastler, Dr. Francesco De Meo, Michael Sen, Rice Powell, Sebastian Biedenkopf
Supervisory board
Wolfgang Kirsch, Grit Genster, Michael Diekmann, Bernd Behlert, Dr. Gerd Krick, Frauke Lehmann, Hauke Stars, Konrad Kölbl, Michael Sen, Oscar Romero De Paco, Prof. Dr. D. Michael Albrecht, Prof. Dr. Iris Löw-Friedrich, Stefanie Balling
 

Company data

Name: Fresenius SE & Co. KGaA
Address: Else-Kröner-Straße 1,D-61352 Bad Homburg
Phone: +49-6172-608-0
Fax: -
E-mail: pr-fre@fresenius.com
Internet: www.fresenius.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 56.49%
IPO date: 12/18/1986

Investor relations

Name: Markus Georgi
IR phone: +49-6172-608-2485
IR Fax: +49-6172-608-2488
IR e-mail: ir-fre@fresenius.com

Company calendar

CW 31 | 7/30/2021 Interim Report 2nd Quarter/6 Months
CW 45 | 11/2/2021 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
56.49%
Else Kröner-Fresenius-Stiftung
 
27.00%
BlackRock, Inc.
 
4.74%
Allianz Global Investors GmbH
 
2.98%
DWS Investment GmbH
 
2.98%
The Capital Group Companies, Inc.
 
2.92%
Henderson Group plc
 
2.89%